Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000442,LEA/Hok,female,90 days,3,,CMO:0001511,liver copper weight to liver wet weight ratio,,,,3.7,ug/g,0.1732,0.3,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107414,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,female,90 days,3,,CMO:0001511,liver copper weight to liver wet weight ratio,,,,223.1,ug/g,3.926,6.8,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107415,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000442,LEA/Hok,male,2 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,200,ug/g,3.8682,6.7,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107404,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000442,LEA/Hok,female,2 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,198.6,ug/g,9.4108,16.3,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107405,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000442,LEA/Hok,male,7 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,209.7,ug/g,6.8705,11.9,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107406,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000442,LEA/Hok,female,7 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,204,ug/g,9.6417,16.7,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107407,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,male,2 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,597.8,ug/g,27.3664,47.4,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107408,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,female,2 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,627.4,ug/g,43.1858,74.8,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107409,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,male,28 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,320.1,ug/g,32.6203,56.5,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107410,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,female,28 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,380,ug/g,56.5226,97.9,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107411,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,male,112 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,1153.3,ug/g,71.6492,124.1,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107412,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,female,112 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,1201.7,ug/g,59.8135,103.6,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107413,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,male,224 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,861.9,ug/g,13.2791,23.0,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107416,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",hepatic copper amount,,RS:0000446,LEC/Hok,female,224 days,3,,CMO:0001512,liver copper weight to liver dry weight ratio,,,,631.1,ug/g,113.1029,195.9,MMO:0000379,flame atomic absorption spectrometry,,0.0,,,,,control condition,107417,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood copper amount,,RS:0000442,LEA/Hok,male,28 days,3,,CMO:0003465,serum copper level,,,,13.6,umol/l,2.3671,4.1,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107501,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood copper amount,,RS:0000442,LEA/Hok,female,28 days,3,,CMO:0003465,serum copper level,,,,14.1,umol/l,0.5196,0.9,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107502,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood copper amount,,RS:0000442,LEA/Hok,male,168 days,3,,CMO:0003465,serum copper level,,,,24.9,umol/l,1.2702,2.2,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107503,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood copper amount,,RS:0000442,LEA/Hok,female,168 days,3,,CMO:0003465,serum copper level,,,,28.2,umol/l,3.0022,5.2,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107504,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood copper amount,,RS:0000446,LEC/Hok,male,168 days,3,,CMO:0003465,serum copper level,,,,5,umol/l,0.9238,1.6,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107505,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood ceruloplasmin amount,,RS:0000442,LEA/Hok,male,7 days,3,,CMO:0003468,serum ceruloplasmin level,,,,205.8,mg/l,26.3849,45.7,MMO:0000728,serum p-phenylenediamine oxidase activity assay,,0.0,serum p-phenylenediamine oxidase activity assay (MMO:0000728),,,,control condition,107515,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood ceruloplasmin amount,,RS:0000442,LEA/Hok,female,7 days,3,,CMO:0003468,serum ceruloplasmin level,,,,192.2,mg/l,8.3138,14.4,MMO:0000728,serum p-phenylenediamine oxidase activity assay,,0.0,serum p-phenylenediamine oxidase activity assay (MMO:0000728),,,,control condition,107522,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood ceruloplasmin amount,,RS:0000442,LEA/Hok,male,28 days,3,,CMO:0003468,serum ceruloplasmin level,,,,552.1,mg/l,48.8438,84.6,MMO:0000728,serum p-phenylenediamine oxidase activity assay,,0.0,serum p-phenylenediamine oxidase activity assay (MMO:0000728),,,,control condition,107523,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",blood ceruloplasmin amount,,RS:0000442,LEA/Hok,female,28 days,3,,CMO:0003468,serum ceruloplasmin level,,,,589,mg/l,17.8979,31.0,MMO:0000728,serum p-phenylenediamine oxidase activity assay,,0.0,serum p-phenylenediamine oxidase activity assay (MMO:0000728),,,,control condition,107524,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",urine copper amount,,RS:0000442,LEA/Hok,male,28 days,3,,CMO:0003493,urine copper level to urine creatinine level ratio,,urine copper level to urine creatinine level ratio (CMO:0003493),,2.78,umol/umol Cr,0.6697,1.16,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107506,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",urine copper amount,,RS:0000442,LEA/Hok,male,168 days,3,,CMO:0003493,urine copper level to urine creatinine level ratio,,urine copper level to urine creatinine level ratio (CMO:0003493),,1.07,umol/umol Cr,0.2887,0.5,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107507,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",urine copper amount,,RS:0000442,LEA/Hok,female,28 days,3,,CMO:0003493,urine copper level to urine creatinine level ratio,,urine copper level to urine creatinine level ratio (CMO:0003493),,2.8,umol/umol Cr,0.6697,1.16,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107508,control condition 3086,"Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011.",urine copper amount,,RS:0000442,LEA/Hok,female,168 days,3,,CMO:0003493,urine copper level to urine creatinine level ratio,,urine copper level to urine creatinine level ratio (CMO:0003493),,3.76,umol/umol Cr,0.8198,1.42,MMO:0000380,graphite furnace atomic absorption spectrometry,,0.0,,,,,control condition,107509,control condition